Parallax Volatility Advisers, L.P. Legend Biotech Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$55.06 - $69.99 $1.38 Million - $1.75 Million	25,000 Added 62.5%	65,000 $3.65 Million
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $2.29 Million - $2.79 Million	40,000 New	40,000 $2.41 Million
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $3.71 Million - $5.31 Million	-105,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $2.71 Million - $4.31 Million	105,000 New	105,000 $4.31 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.68B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.